Navigation Links
Savient's Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase
Date:11/19/2008

FORWARD-LOOKING LANGUAGE

All statements other than statements of historical facts included in this press release are forward-looking statements that are subject to certain risks, trends and uncertainties that could cause actual results and achievements to differ materially from those expressed in such statements. These risks, trends and uncertainties are in some instances beyond our control. Words such as "anticipate," "believe," "estimate," "expect," "intend," "plan," "will" and other similar expressions help identify forward-looking statements, although not all forward-looking statements contain these identifying words. In particular, any statements regarding our BLA filing with the FDA, a potential Advisory Committee, approval of the BLA, preparation for commercialization of pegloticase, the efficacy and safety of pegloticase, the market for pegloticase, and the absence of other therapies for treatment-failure gout patients, are forward-looking statements. These forward-looking statements involve substantial risks and uncertainties and are based on our current assessment of the Phase 3 clinical data and on current expectations, assumptions, estimates and projections about our business and the biopharmaceutical and specialty pharmaceutical industries in which we operate. Important factors that may affect our ability to achieve the matters addressed in these forward-looking statements include, but are not limited to, the delay or failure in completing development of pegloticase and developing other product candidates; our stock price and market conditions; varying interpretations of our clinical and CMC data by the FDA; delay achieving or failure to achieve FDA approval of pegloticase; inability to manufacture commercial quantities of our products; inability to gain market acceptance sufficient to justify development and commercialization costs if our products are approved for marketing; our continuing to incur substanti
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
2. Richard Greco Joins Mediware Board
3. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
4. Award-winning QUITPLAN(R) Services Billboard Debuts in Rogers
5. Montana Health Care Leader Elected Board Chair of National Association
6. Genaera Announces Formation of Scientific Advisory Board for Obesity Drug Candidate Trodusquemine (MSI-1436)
7. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
8. Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting
9. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
10. Patient Safety Authority Board of Directors Names Infection Advisory Panel
11. William Moore Appointed to IRIDEX Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... April 28, 2015 New and ... require more of manufacturers, payers, pharmacists and patients. ... premier journal, is partnering with the National Association ... association dedicated solely to this developing field to ... this growing need. , “This partnership creates a ...
(Date:4/28/2015)... 2015 A first-in-human prostate cancer ... Imaging and Biology showed initial safety, biodistribution, and ... labeled small-molecule PSMA inhibitor. The imaging biomarker has ... MD by study co-author, Martin G. Pomper, MD, ... [18F]DCFPyL demonstrated a number of important findings. ...
(Date:4/28/2015)... April 28, 2015 Researchers from four ... dose of a steroid prior to pemetrexed (Alimta) chemotherapy ... reaction. Click here to read the full story ... from the Raabe College of Pharmacy in Ohio, Stanford ... Appalachian Regional Healthcare in Kentucky gave a single dose ...
(Date:4/28/2015)... (PRWEB) April 28, 2015 It’s not all ... L. Schneiderman . For Schneiderman, a civil litigation and plaintiff’s ... analyst on TV and radio networks, it’s also about giving ... native recently joined the Fred Hutchinson Cancer Research Center Innovator’s ... to do in the community, and lawyers can and do ...
(Date:4/28/2015)... OsteoRemedies®, LLC, Memphis, TN, offers ... of infected hip and knee arthroplasty. ... pre-formed, pre-loaded spacer with Gentamicin Antibiotics, for consistent ... Combined with a consistent process for polishing ... approved for temporary use for up to 180 ...
Breaking Medicine News(10 mins):Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 2Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 3Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 4Health News:Second Generation 18F-labeled Prostate-Specific Membrane Antigen (PSMA) Targeted Imaging Agent Found to be Highly Sensitive in Detecting Prostate Cancer 2Health News:Second Generation 18F-labeled Prostate-Specific Membrane Antigen (PSMA) Targeted Imaging Agent Found to be Highly Sensitive in Detecting Prostate Cancer 3Health News:Study Finds New Regimen May Ward Off Skin Rash from Common Mesothelioma Drug, According to Surviving Mesothelioma 2Health News:Seattle Attorney Paul Schneiderman Helping to Combat Cancer 2
... DIEGO, March 20 CryoCor, Inc. (Nasdaq:,CRYO), a medical ... reported on its financial results for the year ended,December ... million, or ($1.31),per share, for the year ended December ... million, or ($1.40) per share, for the year ended ...
... 20 Arthur J. Gallagher &,Co. today ... LLC,headquartered in Fort Washington, Pennsylvania. Terms of ... 2002, Healthcare Risk Solutions, LLC is a ... associated risk mitigation consulting services and specialized,program ...
... smell occurs in the earliest stages of Parkinsons disease ... precede motor symptoms by several years, although no large-scale ... the general population, researchers found that smell impairment can ... least four years. The study is published in the ...
... UN initiative seeks to halve by 2015 the number of ... Sanitation pays: For every dollar spent installing toilets in ... health and other benefits, according to a UN report released ... seeks to halve by 2015 the number of people worldwide ...
... Chad Karasaki joins Honolulu office as managing director, ... the leading provider of global risk management services, ... Services Group as,managing director. Karasaki, who will also ... office, is the latest in a series of ...
... Oregon doctoral students dove into issues of transgender identities -- ... a call for psychologists and vocational counselors to not only ... and to help end discrimination in the workplace. , "One ... only do we need to be, as vocational psychologists or ...
Cached Medicine News:Health News:CryoCor Reports 2007 Results 2Health News:CryoCor Reports 2007 Results 3Health News:CryoCor Reports 2007 Results 4Health News:CryoCor Reports 2007 Results 5Health News:CryoCor Reports 2007 Results 6Health News:CryoCor Reports 2007 Results 7Health News:CryoCor Reports 2007 Results 8Health News:Impaired sense of smell may be early indicator of Parkinson's disease 2Health News:Cleaning Up the World's Sanitation 2Health News:Aon Construction Services Group Hires Veteran Industry Expert to Lead Hawaii Operations 2Health News:Aon Construction Services Group Hires Veteran Industry Expert to Lead Hawaii Operations 3Health News:Counselors should target discrimination and be advocates for transgender clients 2Health News:Counselors should target discrimination and be advocates for transgender clients 3
(Date:4/28/2015)... , April 28, 2015 The current ... sixth funding cycle for U.S.- Israel joint ... Efficiency. To be considered, a project proposal must ... company and a university/research institution (one from the U.S. and ... have significant commercial potential and the project outcome should lead ...
(Date:4/27/2015)... April 27, 2015 Techpool Bio-Pharma Co has experienced ... of its new chief executive officer, transforming from a traditional ... Henry Lee took office in 2011, he was ... field, including Novartis and Eisai, with more than 20 years ... and the Asia-Pacific region. ...
(Date:4/27/2015)... April 27, 2015  Consumer Watchdog today applauded ... that requires prescribers to check a state database ... OxyContin and other opioids – to help prevent ... SB 482, authored by Sen. ... , will require prescribers to check Controlled Substance ...
Breaking Medicine Technology:Opportunities for Funding U.S.-Israel Cooperation for Renewable Energy and Efficiency 2Techpool Transforms Into International Player 2Techpool Transforms Into International Player 3Consumer Watchdog Praises Passage of Bill that Requires Physicians Check Prescription Drug Database Before Prescribing Powerful, Addictive Medications 2Consumer Watchdog Praises Passage of Bill that Requires Physicians Check Prescription Drug Database Before Prescribing Powerful, Addictive Medications 3
... BEACH, Fla., Nov. 10, 2010 The Halifax Health ... as Speediatrics, celebrated the beginning of a new decade ... children,s unit during a ceremony held this afternoon in ... NASCAR Foundation and Halifax Health will celebrate the 10th ...
... Nov. 10, 2010 Everyday, a growing number of ... stay healthy.  To help consumers better understand prescription drug ... online drug comparison tool.  For the first time, people ... safety, effectiveness, convenience and price, and receive tips on ...
Cached Medicine Technology:Speediatrics Unit Celebrates 10th Anniversary 2Speediatrics Unit Celebrates 10th Anniversary 3AARP, Health Publication Join to Create Online Tool to Help Manage Drug Decisions 2
QC HGB is an assayed quality control material for Hemocue analyzers. This control is a solution of stabilized human red cells and is available in 3 levels for monitoring analyzer performance at sever...
VertiGraft allografts for spine surgery deliver the strength adn performance you demand in your procedures and they are backed by quality and safety standards that are unmatched in the industry....
... for every general surgery need. No matter ... the GO450/GO400 Omni-Flex™ General Retractor Systems give ... the best possible exposure in the simplest ... and the hinged extension arm, the GO450 ...
Specifically designed to address the requirements of spine specialists performing vertebroplasty or kyphoplasty procedures....
Medicine Products: